SCHEMBL4063809

SCHEMBL4063809

CCOC(=O)c1cc(-c2ccc(Cl)s2)on1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.62
NPSR1 Q6W5P4 1/20 0.62
ACR P10323 1/20 0.50
MAPT P10636 9/20 0.49
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 2/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
POLB P06746 2/20 0.47
TP53 P04637 2/20 0.44
THRB P10828 1/20 0.43
LMNA P02545 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NOTUM Q6P988 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27176304 0.87 MAPT (0.48) L3MBTL1NPSR1ACRMAPTALDH1A1
SCHEMBL20507301 0.84 MAPT (0.46) L3MBTL1NPSR1ACRMAPTALDH1A1
SCHEMBL1456889 0.81 F10 (0.56) L3MBTL1NPSR1ALDH1A1KDM4EHPGD
SCHEMBL4069525 0.80 NPSR1 (0.54) L3MBTL1NPSR1MAPTALDH1A1KDM4E
SCHEMBL1456447 0.79 F10 (0.46) L3MBTL1NPSR1ALDH1A1KDM4EHPGD
SCHEMBL11902623 0.78 ALDH1A1 (0.53) NPSR1MAPTALDH1A1KDM4EHPGD
SCHEMBL1686347 0.78 POLB (0.66) L3MBTL1ACRMAPTALDH1A1HPGD
SCHEMBL5035527 0.77 F10 (0.59) L3MBTL1NPSR1ALDH1A1KDM4EHPGD
SCHEMBL508571 0.77 KMT2A (0.61) NPSR1MAPTALDH1A1KDM4EHPGD
SCHEMBL21523702 0.77 MAPT (0.46) L3MBTL1ACRMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208097-B1 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMA INC (US) 2009-02-18 EP disclosed
EP-1208097-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS Aventis Pharmaceuticals Inc. (US) 2002-05-29 EP disclosed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO disclosed